Literature DB >> 24950671

Rotors as drivers of atrial fibrillation and targets for ablation.

Amir A Schricker1, Gautam G Lalani, David E Krummen, Sanjiv M Narayan.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia targeted by catheter ablation. Despite significant advances in our understanding of AF, ablation outcomes remain suboptimal, and this is due in large part to an incomplete understanding of the underlying sustaining mechanisms of AF. Recent developments of patient-tailored and physiology-based computational mapping systems have identified localized electrical spiral waves, or rotors, and focal sources as mechanisms that may represent novel targets for therapy. This report provides an overview of Focal Impulse and Rotor Modulation (FIRM) mapping, which reveals that human AF is often not actually driven by disorganized activity but instead that disorganization is secondary to organized rotors or focal sources. Targeted ablation of such sources alone can eliminate AF and, when added to pulmonary vein isolation, improves long-term outcome compared with conventional ablation alone. Translating mechanistic insights from such patient-tailored mapping is likely to be crucial in achieving the next major advances in personalized medicine for AF.

Entities:  

Mesh:

Year:  2014        PMID: 24950671      PMCID: PMC4121057          DOI: 10.1007/s11886-014-0509-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  55 in total

1.  Stationary and drifting spiral waves of excitation in isolated cardiac muscle.

Authors:  J M Davidenko; A V Pertsov; R Salomonsz; W Baxter; J Jalife
Journal:  Nature       Date:  1992-01-23       Impact factor: 49.962

2.  Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle.

Authors:  M A Allessie; F I Bonke; F J Schopman
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

3.  Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs.

Authors:  P L Rensma; M A Allessie; W J Lammers; F I Bonke; M J Schalij
Journal:  Circ Res       Date:  1988-02       Impact factor: 17.367

4.  A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo.

Authors:  M R Franz; M C Chin; H R Sharkey; J C Griffin; M M Scheinman
Journal:  J Am Coll Cardiol       Date:  1990-10       Impact factor: 24.094

5.  Evidence for transient linking of atrial excitation during atrial fibrillation in humans.

Authors:  E P Gerstenfeld; A V Sahakian; S Swiryn
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

6.  Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium.

Authors:  R B Schuessler; T M Grayson; B I Bromberg; J L Cox; J P Boineau
Journal:  Circ Res       Date:  1992-11       Impact factor: 17.367

7.  High-density mapping of electrically induced atrial fibrillation in humans.

Authors:  K T Konings; C J Kirchhof; J R Smeets; H J Wellens; O C Penn; M A Allessie
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

8.  Termination of persistent atrial fibrillation resistant to cardioversion by a single radiofrequency application.

Authors:  Bengt Herweg; Marcin Kowalski; Jonathan S Steinberg
Journal:  Pacing Clin Electrophysiol       Date:  2003-06       Impact factor: 1.976

9.  Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry.

Authors:  John M Miller; Robert C Kowal; Vijay Swarup; James P Daubert; Emile G Daoud; John D Day; Kenneth A Ellenbogen; John D Hummel; Tina Baykaner; David E Krummen; Sanjiv M Narayan; Vivek Y Reddy; Kalyanam Shivkumar; Jonathan S Steinberg; Kevin R Wheelan
Journal:  J Cardiovasc Electrophysiol       Date:  2014-07-23

10.  The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation.

Authors:  J L Cox; T E Canavan; R B Schuessler; M E Cain; B D Lindsay; C Stone; P K Smith; P B Corr; J P Boineau
Journal:  J Thorac Cardiovasc Surg       Date:  1991-03       Impact factor: 5.209

View more
  6 in total

1.  Role of Rotors in the Ablative Therapy of Persistent Atrial Fibrillation.

Authors:  Amir A Schricker; Junaid Zaman
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-05-30

2.  Pathophysiology and Management of Arrhythmias Associated with Atrial Septal Defect and Patent Foramen Ovale.

Authors:  Henry Chubb; John Whitaker; Steven E Williams; Catherine E Head; Natali Ay Chung; Matthew J Wright; Mark O'Neill
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

3.  Successful atrial fibrillation ablation without pulmonary vein isolation utilizing focal impulse and rotor mapping in an atriopulmonary Fontan.

Authors:  Madhukar Kollengode; Jehu Mathew; Elizabeth Yeung; William H Sauer; Duy Thai Nguyen
Journal:  HeartRhythm Case Rep       Date:  2018-04-05

Review 4.  Cryoballoon ablation for atrial fibrillation: Effects on neuromodulation.

Authors:  Alvise Del Monte; Luigi Pannone; Antonio Bisignani; Thiago G Osório; Saverio Iacopino; Gian-Battista Chierchia; Carlo de Asmundis
Journal:  Front Cardiovasc Med       Date:  2022-07-28

5.  Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance.

Authors:  Michael Quail; Karl Grunseich; Lauren A Baldassarre; Hamid Mojibian; Mark A Marieb; Daniel Cornfeld; Aaron Soufer; Albert J Sinusas; Dana C Peters
Journal:  J Cardiovasc Magn Reson       Date:  2019-01-03       Impact factor: 5.364

6.  Standardizing Single-Frame Phase Singularity Identification Algorithms and Parameters in Phase Mapping During Human Atrial Fibrillation.

Authors:  Xin Li; Tiago P Almeida; Nawshin Dastagir; María S Guillem; João Salinet; Gavin S Chu; Peter J Stafford; Fernando S Schlindwein; G André Ng
Journal:  Front Physiol       Date:  2020-07-21       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.